Bangma C - Search Results

1

A first step towards a global nomogram to predict disease progression for men on active surveillance.

Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, Nieboer D, Bangma C, Frydenberg M, Rannikko A, Lee LS, Gnanapragasam V, Kattan MW; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Van Hemelrijck M, et al. Among authors: bangma c. Transl Androl Urol. 2021 Mar;10(3):1102-1109. doi: 10.21037/tau-20-1082. Transl Androl Urol. 2021. PMID: 33850745 Free PMC article.

2

Screening and early detection of prostate cancer.

Schröder FH, Alexander FE, Bangma CH, Hugosson J, Smith DS. Schröder FH, et al. Among authors: bangma ch. Prostate. 2000 Aug 1;44(3):255-63. doi: 10.1002/1097-0045(20000801)44:3<255::aid-pros11>3.0.co;2-i. Prostate. 2000. PMID: 10906743 Review. No abstract available.

3

Algorithms based on prostate-specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false-positive PSA results in prostate cancer screening.

Finne P, Finne R, Bangma C, Hugosson J, Hakama M, Auvinen A, Stenman UH. Finne P, et al. Among authors: bangma c. Int J Cancer. 2004 Aug 20;111(2):310-5. doi: 10.1002/ijc.20250. Int J Cancer. 2004. PMID: 15197788 Free article. Clinical Trial.

4

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.

van Gils MP, Stenman UH, Schalken JA, Schröder FH, Luider TM, Lilja H, Bjartell A, Hamdy FC, Pettersson KS, Bischoff R, Takalo H, Nilsson O, Mulders PF, Bangma CH. van Gils MP, et al. Among authors: bangma ch. Eur Urol. 2005 Dec;48(6):1031-41. doi: 10.1016/j.eururo.2005.06.009. Epub 2005 Jul 1. Eur Urol. 2005. PMID: 16054748 Review.

5

The human PC346 xenograft and cell line panel: a model system for prostate cancer progression.

Marques RB, van Weerden WM, Erkens-Schulze S, de Ridder CM, Bangma CH, Trapman J, Jenster G. Marques RB, et al. Eur Urol. 2006 Feb;49(2):245-57. doi: 10.1016/j.eururo.2005.12.035. Epub 2006 Jan 6. Eur Urol. 2006. PMID: 16413664 Review.

6

Does PSA velocity predict prostate cancer in pre-screened populations?

Schröder FH, Roobol MJ, van der Kwast TH, Kranse R, Bangma CH. Schröder FH, et al. Eur Urol. 2006 Mar;49(3):460-5; discussion 465. doi: 10.1016/j.eururo.2005.12.026. Epub 2006 Jan 17. Eur Urol. 2006. PMID: 16442212

7

Bladder carcinogenesis, in search of clues and genes.

Bangma C, Jenster G. Bangma C, et al. Eur Urol. 2006 Aug;50(2):205-7. doi: 10.1016/j.eururo.2006.02.019. Epub 2006 Feb 28. Eur Urol. 2006. PMID: 16530924 No abstract available.

8

Evolution of the androgen receptor pathway during progression of prostate cancer.

Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G. Hendriksen PJ, et al. Cancer Res. 2006 May 15;66(10):5012-20. doi: 10.1158/0008-5472.CAN-05-3082. Cancer Res. 2006. PMID: 16707422 Free article.

9

Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance.

Roemeling S, Roobol MJ, Postma R, Gosselaar C, van der Kwast TH, Bangma CH, Schröder FH. Roemeling S, et al. Among authors: bangma ch. Eur Urol. 2006 Sep;50(3):475-82. doi: 10.1016/j.eururo.2006.04.019. Epub 2006 May 3. Eur Urol. 2006. PMID: 16713065

10

Prostate cancer in the Swedish section of ERSPC--evidence for less metastases at diagnosis but not for mortality reduction.

Schröder FH, Habbema DF, Roobol MJ, Bangma CH. Schröder FH, et al. Eur Urol. 2007 Mar;51(3):588-90. doi: 10.1016/j.eururo.2006.07.013. Epub 2006 Jul 28. Eur Urol. 2007. PMID: 16911853 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

371 results

Search Page